CS

Charanjit Singh

Active Director Director DIN 09246434
DIN 09246434 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Charanjit Singh

Data last updated:

Charanjit Singh is a Director at Vilcant Pharma Private Limited (since 2021). The company operates in Chemicals. Vilcant Pharma Private Limited reported revenue of ₹16 Lakh (FY 2023).

DIN 09246434
Primary Designation Director
Industry Chemicals
First Appointment 20 Jul 2021
Oldest Company Age 5 yrs
Largest company Vilcant Pharma Private Limited · ₹16 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vilcant Pharma Private Limited U24299HR2021PTC096436
Director20 Jul 20212021₹16 Lakh (FY 2023)Active

Board colleagues of Charanjit Singh

NameDINCompanyDesignation
Laval Jit Singh09246435Vilcant Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vilcant Pharma Private Limited
Premium access

Shareholding and investment profile for Charanjit Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charanjit Singh

Charanjit Singh currently holds 1 directorship: Vilcant Pharma Private Limited (Director, since 20 Jul 2021, revenue ₹16 Lakh (FY 2023)).

Charanjit Singh was first appointed on 20 Jul 2021 as Director at Vilcant Pharma Private Limited.

The current boards of Charanjit Singh's companies include Laval Jit Singh (Vilcant Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available